Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. (Q54236131)

16 June 2018

title

Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. (English)

1 reference

16 June 2018

1 reference

1 reference

Wilson R

1

1 reference

16 June 2018

Kubin R

2

1 reference

16 June 2018

Ballin I

3

1 reference

16 June 2018

Deppermann KM

4

1 reference

16 June 2018

Bassaris HP

5

1 reference

16 June 2018

Leophonte P

6

1 reference

16 June 2018

Schreurs AJ

7

1 reference

16 June 2018

Torres A

8

1 reference

16 June 2018

Sommerauer B

9

1 reference

16 June 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

16 June 2018

Journal of Antimicrobial Chemotherapy

published in

1 reference

16 June 2018

volume

44

1 reference

16 June 2018

issue

4

1 reference

16 June 2018

page(s)

501-513

1 reference

16 June 2018

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

cites work

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Antibiotic resistance and serotypes of 100 Streptococcus pneumoniae strains isolated in a children's hospital in Barcelona, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

Outcome Predictors in Bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JAC/44.4.501

21 January 2018

Identifiers

DOI

10.1093/JAC/44.4.501

1 reference

16 June 2018

release_wsxsn6dvnvachn2gylagzcokeu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wsxsn6dvnvachn2gylagzcokeu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

16 June 2018